These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 9876503

  • 1. Evaluation of dosage forms. IV. Studies on commercial phenylbutazone tablet dosage forms.
    Razdan B, Paradkar AR.
    Drug Dev Ind Pharm; 1998 Jul; 24(7):599-604. PubMed ID: 9876503
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The objective and timing of drug disposition studies, appendix IV. Phenylbutazone formulations: in vitro dissolution and in vivo performance.
    Leeson LJ, Shinal EC, Lukas G, Zak SB, Weiner M.
    Drug Metab Rev; 1975 Jul; 4(2):277-84. PubMed ID: 1222684
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
    Ahmed IS, Aboul-Einien MH.
    Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
    [Abstract] [Full Text] [Related]

  • 6. In-vitro and in-vivo correlation of enhancement of dissolution rate of water insoluble drugs.
    al-Meshal MA.
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):415-8. PubMed ID: 2343187
    [Abstract] [Full Text] [Related]

  • 7. Correlation of in vivo bioavailability of erythromycin stearate tablets with in vitro tests.
    Stavchansky S, Doluisio JT, Martin A, Martin C, Cabana B, Dighe S, Loper A.
    J Pharm Sci; 1980 Nov; 69(11):1307-10. PubMed ID: 7452460
    [Abstract] [Full Text] [Related]

  • 8. Correlation between in vitro and in vivo parameters of commercial paracetamol tablets.
    Babalola CP, Oladimeji FA, Femi-Oyewo MN.
    Afr J Med Med Sci; 2001 Dec; 30(4):275-80. PubMed ID: 14510103
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and bioavailability of a controlled release amoxicillin formulation.
    Arancibia A, González G, Icarte A, Arancibia M, Arancibia P.
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):97-100. PubMed ID: 3557736
    [Abstract] [Full Text] [Related]

  • 11. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S, Belpaire F, Moerman E.
    Pharmazie; 1980 Feb; 35(10):627-9. PubMed ID: 7454745
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The bioavailability of diazepam from uncoated tablets in humans--Part I: correlation with the dissolution rates of the tablets.
    Ogata H, Aoyagi N, Kaniwa N, Koibuchi M, Shibazaki T, Ejima A, Tsuji S, Kawazu Y.
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):159-65. PubMed ID: 7076345
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Studies on the bioavailability of nitrendipine tablet].
    Zhu ZY, Mao FF, Zhu JB.
    Yao Xue Xue Bao; 1990 Apr; 25(9):709-16. PubMed ID: 2092581
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo characteristics of some commercial phenobarbital tablets.
    Sylvestri MF, Ueda CT.
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):492-7. PubMed ID: 528095
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.